dehydroepiandrosterone has been researched along with Cirrhosis in 8 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The following study investigates the ovarian hyperfibrosis forming via transforming growth factor-β (TGF-β) signaling pathway in Dehydroepiandrosterone (DHEA)- induced polycystic ovary syndrome (PCOS) rat model." | 3.88 | DHEA-induced ovarian hyperfibrosis is mediated by TGF-β signaling pathway. ( Gao, Q; He, X; Liang, Q; Shen, S; Wang, D; Wang, H; Wang, W; Wang, Y; Xia, Y, 2018) |
| " Dehydroepiandrosterone (DHEA) effectively treats experimental pulmonary hypertension in chronically hypoxic and monocrotaline-injected rats." | 3.79 | Dehydroepiandrosterone restores right ventricular structure and function in rats with severe pulmonary arterial hypertension. ( Abe, K; Alzoubi, A; Fagan, KA; McMurtry, IF; O'Neill, KD; Oka, M; Rocic, P; Toba, M, 2013) |
| "Dehydroepiandrosterone (DHEA) is an abundant steroid and precursor of sex hormones." | 1.91 | DHEA and Its Metabolites Reduce the Cytokines Involved in the Inflammatory Response and Fibrosis in Primary Biliary Cholangitis. ( Blatkiewicz, M; Kilańczyk, E; Piotrowska, K; Sielatycka, K, 2023) |
| "Dehydroepiandrosterone (DHEA) is a naturally occurring adrenal androgen that has antioxidant properties." | 1.37 | The effect of DHEA treatment on the oxidative stress and myocardial fibrosis induced by Keshan disease pathogenic factors. ( Chen, X; Fan, Z; Jia, C; Li, M; Li, X; Miao, C; Ren, L; Sun, B, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Blatkiewicz, M | 1 |
| Sielatycka, K | 1 |
| Piotrowska, K | 1 |
| Kilańczyk, E | 1 |
| Chen, L | 1 |
| Li, M | 2 |
| Shen, M | 1 |
| Zhu, Y | 1 |
| Chen, K | 1 |
| Huang, X | 1 |
| Zheng, C | 1 |
| Wang, Q | 1 |
| Lin, H | 1 |
| Liao, W | 1 |
| Bin, J | 1 |
| Ma, S | 1 |
| Liao, Y | 1 |
| Weng, Y | 1 |
| Zhang, Y | 1 |
| Wang, D | 2 |
| Wang, R | 1 |
| Xiang, Z | 1 |
| Shen, S | 3 |
| Wang, H | 2 |
| Wu, X | 1 |
| Wen, Y | 1 |
| Wang, Y | 3 |
| Wang, W | 1 |
| Liang, Q | 1 |
| He, X | 1 |
| Xia, Y | 1 |
| Gao, Q | 2 |
| Alzoubi, A | 1 |
| Toba, M | 1 |
| Abe, K | 1 |
| O'Neill, KD | 1 |
| Rocic, P | 1 |
| Fagan, KA | 1 |
| McMurtry, IF | 1 |
| Oka, M | 1 |
| Zhang, X | 1 |
| Zhang, C | 1 |
| Xia, Yj | 1 |
| Yi, L | 1 |
| Jia, C | 1 |
| Chen, X | 1 |
| Li, X | 1 |
| Miao, C | 1 |
| Sun, B | 1 |
| Fan, Z | 1 |
| Ren, L | 1 |
| Aragno, M | 1 |
| Mastrocola, R | 1 |
| Alloatti, G | 1 |
| Vercellinatto, I | 1 |
| Bardini, P | 1 |
| Geuna, S | 1 |
| Catalano, MG | 1 |
| Danni, O | 1 |
| Boccuzzi, G | 1 |
8 other studies available for dehydroepiandrosterone and Cirrhosis
| Article | Year |
|---|---|
DHEA and Its Metabolites Reduce the Cytokines Involved in the Inflammatory Response and Fibrosis in Primary Biliary Cholangitis.
Topics: Aged; Cytokines; Dehydroepiandrosterone; Female; Fibrosis; Humans; Interleukin-8; Interleukins; Live | 2023 |
Bioinformatics exploration of potential common therapeutic targets for systemic and pulmonary arterial hypertension-induced myocardial hypertrophy.
Topics: Animals; Cardiomegaly; Computational Biology; Dehydroepiandrosterone; Fibrosis; Hypertrophy, Left Ve | 2023 |
Exercise-induced irisin improves follicular dysfunction by inhibiting IRE1α-TXNIP/ROS-NLRP3 pathway in PCOS.
Topics: Animals; Carrier Proteins; Cell Cycle Proteins; Dehydroepiandrosterone; Endoribonucleases; Female; F | 2023 |
DHEA-induced ovarian hyperfibrosis is mediated by TGF-β signaling pathway.
Topics: Animals; Biomarkers; Dehydroepiandrosterone; Disease Models, Animal; Estrous Cycle; Female; Fibrosis | 2018 |
Dehydroepiandrosterone restores right ventricular structure and function in rats with severe pulmonary arterial hypertension.
Topics: Animals; Apoptosis; Blood Pressure; Dehydroepiandrosterone; Fibrosis; Gene Expression; Heart Ventric | 2013 |
Dehydroepiandrosterone induces ovarian and uterine hyperfibrosis in female rats.
Topics: Animals; Dehydroepiandrosterone; Female; Fibrosis; Hypoglycemic Agents; Hypolipidemic Agents; Metfor | 2013 |
The effect of DHEA treatment on the oxidative stress and myocardial fibrosis induced by Keshan disease pathogenic factors.
Topics: Animals; Body Weight; Cardiomyopathies; Connective Tissue Growth Factor; Dehydroepiandrosterone; Dis | 2011 |
Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats.
Topics: Animals; Connective Tissue Growth Factor; Dehydroepiandrosterone; Diabetes Mellitus, Experimental; D | 2008 |